Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies ...

On the heels of a private equity buyout campaign that ultimately fell flat, Bavarian Nordic’s board chair is stepping aside.

Kyowa Kirin’s big bet on Kura Oncology has paid off in short order, delivering an FDA approval for a medicine to treat a ...

Gilead Sciences has developed an industry-leading HIV portfolio in recent years with its megablockbuster daily treatment ...

The project will expand Boryung’s oral penicillin antibiotic production line at its campus in Ansan, South Korea, from 2,777 ...

Since the start of the month, several drug recalls have entered the FDA’s periphery, affecting products ranging from hospital ...

As Lundbeck and Otsuka count on prescriptions in agitation associated with dementia due to Alzheimer’s disease (AADAD) to ...

In a surprise move, the FDA has named the longtime leader of its oncology department, Richard Pazdur, M.D., as the new ...

Johnson & Johnson and Legend Biotech are said to have withdrawn an abstract originally planned for next month’s Amer | “At this point, the abstract was withdrawn in alignment with the authors, and we ...

Tanvi Lodhia’s path to pharma marketing may sound familiar to her peers in the industry: Like many of them, for example, she ...

Eli Lilly’s Zepbound push is getting a “Queer Eye” makeover with the help of fashion expert Tan France, who is joining the ...

Amid a rise in misinformation and pseudoscientific beliefs, a new corporate push from Bayer seeks to remind Americans of the ...